U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H3N4O2.Na
Molecular Weight 174.0927
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Sodium xanthinate

SMILES

[Na+].OC1=NC2=C(NC=N2)C([O-])=N1

InChI

InChIKey=HKDXLLDCXWUUKY-UHFFFAOYSA-M
InChI=1S/C5H4N4O2.Na/c10-4-2-3(7-1-6-2)8-5(11)9-4;/h1H,(H3,6,7,8,9,10,11);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C5H4N4O2
Molecular Weight 152.1109
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues.
2001-07-06
Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation.
2001-05-05
Miniaturized amperometric biosensor based on xanthine oxidase for monitoring hypoxanthine in cell culture media.
2001-05-01
Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
2001-05
Xanthine oxidase inhibitory activity of selected Australian native plants.
2001-05
Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia.
2001-04-27
Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II.
2001-04-20
Effects of tocopheryl quinone on the heart: model experiments with xanthine oxidase, heart mitochondria, and isolated perfused rat hearts.
2001-04-15
Insight into the chemistry of flavin reduction and oxidation in Escherichia coli dihydroorotate dehydrogenase obtained by rapid reaction studies.
2001-04-10
Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors.
2001-04-09
Effect of poly ICLC treatment on hepatic oxidative stress and antioxidant defense indices in Plasmodium yoelii nigeriensis infected mice.
2001-04-05
Reactive oxygen species (ROS)-generating oxidases in the normal rabbit cornea and their involvement in the corneal damage evoked by UVB rays.
2001-04
Photoreactivation of alloxanthine-inhibited xanthine oxidase.
2001-04
Abnormal Ca2+ signalling in vascular endothelial cells from spontaneously hypertensive rats: role of free radicals.
2001-04
Serum xanthine oxidase in human liver disease.
2001-04
Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants.
2001-04
Properties of tomato powders as additives for food fortification and stabilization.
2001-04
Analysis of peroxynitrite reactions with guanine, xanthine, and adenine nucleosides by high-pressure liquid chromatography with electrochemical detection: C8-nitration and -oxidation.
2001-04
Effect of reactive oxygen species on fetal lung maturation.
2001-04
Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis.
2001-04
Functional characterization of a maize purine transporter by expression in Aspergillus nidulans.
2001-04
The chemical work of Alexander and Jane Marcet.
2001-04
Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia.
2001-04
The effects of delta sleep-inducing peptide on the intensity of lipid peroxidation and xanthine oxidase activity in rat tissues during cold stress.
2001-03-27
Cytochrome C is a potent catalyst of dichlorofluorescin oxidation: implications for the role of reactive oxygen species in apoptosis.
2001-03-23
Effects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells.
2001-03-15
Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells.
2001-03-15
Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals.
2001-03-15
Astrocytes overexpressing Cu,Zn superoxide dismutase have increased resistance to oxidative injury.
2001-03-15
Asafoetida inhibits early events of carcinogenesis: a chemopreventive study.
2001-03-09
ESR studies on reaction of saccharide with the free radicals generated from the xanthine oxidase/hypoxanthine system containing iron.
2001-03-09
Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue. Its potential role in alcohol-promoted mammary cancer.
2001-03-07
Tautomeric energetics of xanthine oxidase substrates: xanthine, 2-oxo-6-methylpurine, and lumazine.
2001-03
The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and alpha1-blockers.
2001-03
Antagonism of free-radical-induced damage of adlay seed and its antiproliferative effect in human histolytic lymphoma U937 monocytic cells.
2001-03
Molecular cloning of a cDNA coding for feline liver xanthine dehydrogenase.
2001-03
Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense.
2001-03
Aryl hydrocarbon receptor (AhR)-mediated induction of xanthine oxidase/xanthine dehydrogenase activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
2001-03
A simple technique for the simultaneous determination of molecular weight and activity of superoxide dismutase using SDS-PAGE.
2001-02-26
Effects of L-arginine cardioplegia on myocardium.
2001-02
Prevention of deleterious effects of reperfusion injury using one-week high-dose allopurinol.
2001-02
Caffeine metabolism before and after liver transplantation.
2001-02
Evaluation of health aspects of kojic acid in food.
2001-02
Characterization of DNA damage at purine residues in oligonucleotides and calf thymus DNA induced by the mutagen 1-nitrosoindole-3-acetonitrile.
2001-02
Cerebral ischemia in humans after traumatic brain injury.
2001-02
Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury.
2001-02
Xanthine oxidase activity and blood glutathione redox ratio in infants and children with septic shock syndrome.
2001-01
Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn.
2001
Free radicals and brain damage in the newborn.
2001
Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
2001
Patents
Substance Class Chemical
Created
by admin
on Tue Apr 01 17:39:21 GMT 2025
Edited
by admin
on Tue Apr 01 17:39:21 GMT 2025
Record UNII
J2QNY3UCX2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1H-Purine-2,6-dione, 3,7-dihydro-, monosodium salt
Preferred Name English
Sodium xanthinate
Common Name English
1H-Purine-2,6-dione, 3,9-dihydro-, sodium salt (1:1)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID8071724
Created by admin on Tue Apr 01 17:39:21 GMT 2025 , Edited by admin on Tue Apr 01 17:39:21 GMT 2025
PRIMARY
CAS
1196-43-6
Created by admin on Tue Apr 01 17:39:21 GMT 2025 , Edited by admin on Tue Apr 01 17:39:21 GMT 2025
PRIMARY
PUBCHEM
14403145
Created by admin on Tue Apr 01 17:39:21 GMT 2025 , Edited by admin on Tue Apr 01 17:39:21 GMT 2025
PRIMARY
ECHA (EC/EINECS)
272-117-7
Created by admin on Tue Apr 01 17:39:21 GMT 2025 , Edited by admin on Tue Apr 01 17:39:21 GMT 2025
NON-SPECIFIC STOICHIOMETRY
CAS
68738-87-4
Created by admin on Tue Apr 01 17:39:21 GMT 2025 , Edited by admin on Tue Apr 01 17:39:21 GMT 2025
NON-SPECIFIC STOICHIOMETRY
ECHA (EC/EINECS)
629-291-8
Created by admin on Tue Apr 01 17:39:21 GMT 2025 , Edited by admin on Tue Apr 01 17:39:21 GMT 2025
PRIMARY
FDA UNII
J2QNY3UCX2
Created by admin on Tue Apr 01 17:39:21 GMT 2025 , Edited by admin on Tue Apr 01 17:39:21 GMT 2025
PRIMARY